More on MCRB
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.13 |
|
|||
| Open | $2.13 | ||||
| 52 Wk High | $44.51 | ||||
| 52 Wk Low | $8.05 | ||||
| Day High | $2.17 | ||||
| Day Low | $2.00 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 69,712 | ||||
- Seres Therapeutics to present SER-428 preclinical data at IDWeek
- Seres Therapeutics to Present Preclinical Data for SER-428, an Investigational Live Biotherapeutic Designed to Reduce Risk of Bloodstream Infections in Critically Ill Patients, at IDWeek 2026
- Form EFFECT Seres Therapeutics, Inc.
- Form 4 Seres Therapeutics, Inc. For: Aug 15 Filed by: Brady Kelly
- Form 4 Seres Therapeutics, Inc. For: Aug 15 Filed by: Shaff Eric D.
- Form 4 Seres Therapeutics, Inc. For: Aug 15 Filed by: Henn Matthew R
- Form 4 Seres Therapeutics, Inc. For: Aug 15 Filed by: DesRosier Thomas
- Seres Therapeutics (MCRB) files $300M mixed shelf
- Form S-3 Seres Therapeutics, Inc.
- Form 10-Q Seres Therapeutics, Inc. For: Jun 30
Entities mentioned with MCRB
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- 13G | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
